Enhanced CXCL12/CXCR4 signaling increases tumor progression in radiation‑resistant pancreatic cancer.
Kato T, Matsuo Y, Ueda G, Murase H, Aoyama Y, Omi K, Hayashi Y, Imafuji H, Saito K, Morimoto M, Ogawa R, Takahashi H, Takiguchi S.
Kato T, et al. Among authors: matsuo y.
Oncol Rep. 2022 Apr;47(4):68. doi: 10.3892/or.2022.8279. Epub 2022 Feb 4.
Oncol Rep. 2022.
PMID: 35119076
Free PMC article.